[HTML][HTML] Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review

AB Boroumand, M Forouhi, F Karimi… - Frontiers in …, 2022 - frontiersin.org
Purpose To evaluate the immunogenicity of COVID-19 vaccines in patients with diabetes
mellitus (DM) through a systematic approach. Method A comprehensive search was …

[HTML][HTML] Challenges in the Vaccination of the Elderly and Strategies for Improvement

G Soegiarto, D Purnomosari - Pathophysiology, 2023 - mdpi.com
In recent years, the elderly has become a rapidly growing proportion of the world's
population as life expectancy is extending. Immunosenescence and inflammaging …

[HTML][HTML] Determinants of humoral and cellular immune responses to three doses of mRNA SARS-CoV-2 vaccines in older adults: A longitudinal cohort study

A Ravussin, AH Robertson, AS Wolf, K Blix… - The Lancet Healthy …, 2023 - thelancet.com
Background Older age is associated with poorer outcomes to COVID-19 infection. The
Norwegian Institute of Public Health established a longitudinal cohort of adults aged 65–80 …

[HTML][HTML] Incidence of SARS-CoV-2 infection in hospital workers before and after vaccination programme in East Java, Indonesia–A retrospective cohort study

G Soegiarto, D Purnomosari, L Wulandari… - The Lancet Regional …, 2023 - thelancet.com
Background The incidence of the Coronavirus Disease 2019 (COVID-19) among healthcare
workers (HCWs) is widespread. It is important to understand COVID-19 characteristics …

[HTML][HTML] Immunogenicity and safety of inactivated SARS-CoV-2 vaccine in haemodialysis patients: A prospective cohort study

M Puspitasari, PD Sattwika, DS Rahari, W Wijaya… - Scientific Reports, 2023 - nature.com
End-stage renal disease patients on haemodialysis (HD) have been largely excluded from
SARS-CoV-2 vaccine trials due to safety reasons and shown to mount lower responses to …

[HTML][HTML] Antibiotic use prior to COVID-19 vaccine is associated with higher risk of COVID-19 and adverse outcomes: a propensity-scored matched territory-wide cohort

KS Cheung, VKC Yan, LK Lam, X Ye, IFN Hung… - Vaccines, 2023 - mdpi.com
Background: Antibiotics may increase the risk of COVID-19 among non-vaccinated subjects
via probable gut dysbiosis. We aimed to investigate whether antibiotics also affect the …

[HTML][HTML] Multimorbidity and serological response to SARS-CoV-2 nine months after 1st vaccine dose: European cohort of healthcare workers—Orchestra project

C Violán, LA Carrasco-Ribelles, G Collatuzzo, G Ditano… - Vaccines, 2023 - mdpi.com
Understanding antibody persistence concerning multimorbidity is crucial for vaccination
policies. Our goal is to assess the link between multimorbidity and serological response to …

[HTML][HTML] Evaluation of antibody response and adverse effects following heterologous COVID-19 vaccine booster with mRNA vaccine among healthcare workers in …

G Soegiarto, BA Mahdi, L Wulandari, KD Fahmita… - Vaccines, 2023 - mdpi.com
Background: The administration of the third (or booster) dose of COVID-19 vaccine is
important in maintaining protection against SARS-CoV-2 infection or the severity of the …

[HTML][HTML] Duration of SARS-CoV-2 RNA shedding is significantly influenced by disease severity, bilateral pulmonary infiltrates, antibiotic treatment, and diabetic status …

MV Arfijanto, TP Asmarawati, B Bramantono, M Rusli… - Pathophysiology, 2023 - mdpi.com
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) ribonucleic acid
(RNA) shedding is an important parameter for determining the optimal length of isolation …

[HTML][HTML] Underlying medical conditions and anti-SARS-CoV-2 spike IgG antibody titers after two doses of BNT162b2 vaccination: A cross-sectional study

J Li, T Nakagawa, M Kojima, A Nishikimi, H Tokuda… - Plos one, 2023 - journals.plos.org
Patients with underlying medical conditions are at high risk of developing serious symptoms
of the coronavirus disease 2019 than healthy individuals; therefore, it is necessary to …